. 2024 Oct 7;32(4):e278895. doi: 10.1590/1413-785220243204e278895
This is an open access article distributed under the terms of the Creative Commons License
Table 3. Epidemiological data.
| Variable | Group | Total (N=40) | p | ||
|---|---|---|---|---|---|
| Placebo (N=16) | Pregabalin 75 mg (N=13) | Pregabalin 150 mg (N=11) | |||
| Age (years) | 0.162** | ||||
| Mean ± SD | 61 ± 14.8 | 51.5 ± 8.2 | 56.2 ± 14.7 | 56.6 ± 13.3 | |
| Median (p25; p75) | 60 (47.5; 75.8) | 54 (47; 57.5) | 52 (41.5; 71.5) | 55 (41; 69) | |
| Gender | 0.088 | ||||
| Female | 15 (93.8) | 12 (92.3) | 7 (63.6) | 34 (85) | |
| Male | 1 (6.3) | 1 (7.7) | 4 (36.4) | 6 (15) | |
| Side | 0.031 | ||||
| Right | 7 (43.8) | 5 (38.5) | 1 (9.1) | 13 (32.5) | |
| Left | 4 (25) | 5 (38.5) | 1 (9.1) | 10 (25) | |
| Bilateral | 5 (31.3) | 3 (23.1) | 9 (81.8) | 17 (42.5) | |
| Time of symptoms (years) | 0.907£ | ||||
| Mean ± SD | 2.7 ± 2.5 | 2.6 ± 2.4 | 2.5 ± 2.5 | 2.6 ± 2.4 | |
| Median (p25; p75) | 2 (1; 3) | 2 (1.5; 3) | 2 (0.7; 3) | 2 (1; 3) | |
Likelihood ratio test
**
Unpaired Student’s T test
£
Kruskal-Wallis test